Literature DB >> 27524438

Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells.

Joshua B Black1, Andrew F Adler1, Hong-Gang Wang2, Anthony M D'Ippolito3, Hunter A Hutchinson1, Timothy E Reddy4, Geoffrey S Pitt5, Kam W Leong1, Charles A Gersbach6.   

Abstract

Overexpression of exogenous fate-specifying transcription factors can directly reprogram differentiated somatic cells to target cell types. Here, we show that similar reprogramming can also be achieved through the direct activation of endogenous genes using engineered CRISPR/Cas9-based transcriptional activators. We use this approach to induce activation of the endogenous Brn2, Ascl1, and Myt1l genes (BAM factors) to convert mouse embryonic fibroblasts to induced neuronal cells. This direct activation of endogenous genes rapidly remodeled the epigenetic state of the target loci and induced sustained endogenous gene expression during reprogramming. Thus, transcriptional activation and epigenetic remodeling of endogenous master transcription factors are sufficient for conversion between cell types. The rapid and sustained activation of endogenous genes in their native chromatin context by this approach may facilitate reprogramming with transient methods that avoid genomic integration and provides a new strategy for overcoming epigenetic barriers to cell fate specification.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27524438      PMCID: PMC5010447          DOI: 10.1016/j.stem.2016.07.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  34 in total

Review 1.  Molecular roadblocks for cellular reprogramming.

Authors:  Thomas Vierbuchen; Marius Wernig
Journal:  Mol Cell       Date:  2012-09-28       Impact factor: 17.970

2.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

Review 3.  Editing the epigenome: technologies for programmable transcription and epigenetic modulation.

Authors:  Pratiksha I Thakore; Joshua B Black; Isaac B Hilton; Charles A Gersbach
Journal:  Nat Methods       Date:  2016-02       Impact factor: 28.547

4.  Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation.

Authors:  Diego Balboa; Jere Weltner; Solja Eurola; Ras Trokovic; Kirmo Wartiovaara; Timo Otonkoski
Journal:  Stem Cell Reports       Date:  2015-09-08       Impact factor: 7.765

5.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors:  Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal:  Nat Biotechnol       Date:  2013-08-01       Impact factor: 54.908

6.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

7.  An encyclopedia of mouse DNA elements (Mouse ENCODE).

Authors:  John A Stamatoyannopoulos; Michael Snyder; Ross Hardison; Bing Ren; Thomas Gingeras; David M Gilbert; Mark Groudine; Michael Bender; Rajinder Kaul; Theresa Canfield; Erica Giste; Audra Johnson; Mia Zhang; Gayathri Balasundaram; Rachel Byron; Vaughan Roach; Peter J Sabo; Richard Sandstrom; A Sandra Stehling; Robert E Thurman; Sherman M Weissman; Philip Cayting; Manoj Hariharan; Jin Lian; Yong Cheng; Stephen G Landt; Zhihai Ma; Barbara J Wold; Job Dekker; Gregory E Crawford; Cheryl A Keller; Weisheng Wu; Christopher Morrissey; Swathi A Kumar; Tejaswini Mishra; Deepti Jain; Marta Byrska-Bishop; Daniel Blankenberg; Bryan R Lajoie; Gaurav Jain; Amartya Sanyal; Kaun-Bei Chen; Olgert Denas; James Taylor; Gerd A Blobel; Mitchell J Weiss; Max Pimkin; Wulan Deng; Georgi K Marinov; Brian A Williams; Katherine I Fisher-Aylor; Gilberto Desalvo; Anthony Kiralusha; Diane Trout; Henry Amrhein; Ali Mortazavi; Lee Edsall; David McCleary; Samantha Kuan; Yin Shen; Feng Yue; Zhen Ye; Carrie A Davis; Chris Zaleski; Sonali Jha; Chenghai Xue; Alex Dobin; Wei Lin; Meagan Fastuca; Huaien Wang; Roderic Guigo; Sarah Djebali; Julien Lagarde; Tyrone Ryba; Takayo Sasaki; Venkat S Malladi; Melissa S Cline; Vanessa M Kirkup; Katrina Learned; Kate R Rosenbloom; W James Kent; Elise A Feingold; Peter J Good; Michael Pazin; Rebecca F Lowdon; Leslie B Adams
Journal:  Genome Biol       Date:  2012-08-13       Impact factor: 13.583

8.  Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system.

Authors:  Albert W Cheng; Haoyi Wang; Hui Yang; Linyu Shi; Yarden Katz; Thorold W Theunissen; Sudharshan Rangarajan; Chikdu S Shivalila; Daniel B Dadon; Rudolf Jaenisch
Journal:  Cell Res       Date:  2013-08-27       Impact factor: 25.617

9.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors.

Authors:  Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Andrew F Adler; Ami M Kabadi; Lauren R Polstein; Pratiksha I Thakore; Katherine A Glass; David G Ousterout; Kam W Leong; Farshid Guilak; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547

10.  Optical control of mammalian endogenous transcription and epigenetic states.

Authors:  Silvana Konermann; Mark D Brigham; Alexandro Trevino; Patrick D Hsu; Matthias Heidenreich; Le Cong; Randall J Platt; David A Scott; George M Church; Feng Zhang
Journal:  Nature       Date:  2013-08-23       Impact factor: 49.962

View more
  70 in total

Review 1.  Manufacturing Cell Therapies Using Engineered Biomaterials.

Authors:  Amr A Abdeen; Krishanu Saha
Journal:  Trends Biotechnol       Date:  2017-07-12       Impact factor: 19.536

Review 2.  CRISPR technologies for precise epigenome editing.

Authors:  Muneaki Nakamura; Yuchen Gao; Antonia A Dominguez; Lei S Qi
Journal:  Nat Cell Biol       Date:  2021-01-08       Impact factor: 28.824

Review 3.  From Reductionism to Holism: Toward a More Complete View of Development Through Genome Engineering.

Authors:  Rebecca K Delker; Richard S Mann
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 4.  Mammalian synthetic biology in the age of genome editing and personalized medicine.

Authors:  Patrick Ho; Yvonne Y Chen
Journal:  Curr Opin Chem Biol       Date:  2017-06-16       Impact factor: 8.822

Review 5.  Bioengineering Solutions for Manufacturing Challenges in CAR T Cells.

Authors:  Nicole J Piscopo; Katherine P Mueller; Amritava Das; Peiman Hematti; William L Murphy; Sean P Palecek; Christian M Capitini; Krishanu Saha
Journal:  Biotechnol J       Date:  2017-09-18       Impact factor: 4.677

Review 6.  Epigenetic regulation in cell senescence.

Authors:  Li-Qin Cheng; Zhu-Qin Zhang; Hou-Zao Chen; De-Pei Liu
Journal:  J Mol Med (Berl)       Date:  2017-09-08       Impact factor: 4.599

7.  CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming.

Authors:  Yanxia Liu; Chen Yu; Timothy Patrick Daley; Fangyuan Wang; William S Cao; Salil Bhate; Xueqiu Lin; Chris Still; Honglei Liu; Dehua Zhao; Haifeng Wang; Xinmin S Xie; Sheng Ding; Wing Hung Wong; Marius Wernig; Lei S Qi
Journal:  Cell Stem Cell       Date:  2018-10-11       Impact factor: 24.633

8.  Human neurons to model aging: A dish best served old.

Authors:  Lena Böhnke; Larissa Traxler; Joseph R Herdy; Jerome Mertens
Journal:  Drug Discov Today Dis Models       Date:  2019-02-12

9.  CRISPR-activation-based screen reveals neuronal fate promotion by polycomb repressive complex 2 during direct reprogramming.

Authors:  Tim Wolfram; Baris Tursun
Journal:  Stem Cell Investig       Date:  2019-09-12

Review 10.  In vivo epigenome editing and transcriptional modulation using CRISPR technology.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  Transgenic Res       Date:  2018-10-04       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.